Intelligence · Clinical Pipeline
ANI PHARMACEUTICALS Pipeline
All ClinicalTrials.gov programs at ANI PHARMACEUTICALS — phase, modality, and trial IDs.
- Programs
- 6
Quick answer
ANI PHARMACEUTICALS has 6 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Fluocinolone Acetonide Intravitreal Implant 0.18 mg
ANI PHARMACEUTICALS INC
Uveitis, Posterior
1 trial -
ILUVIEN
ANI PHARMACEUTICALS INC
Chronic Diabetic Macular Edema
1 trial -
ILUVIEN 0.19 MG
ANI PHARMACEUTICALS INC
Diabetic Macular Edema (DME)
1 trial -
Iluvien 0.19 MG Drug Implant
ANI PHARMACEUTICALS INC
Diabetic Macular Edema
1 trial -
Purified Cortophin Gel, 40 U
ANI PHARMACEUTICALS INC
Gout Arthritis
1 trial -
fluocinolone acetonide 190 micrograms
ANI PHARMACEUTICALS INC
Non-infectious Uveitis Affecting the Posterior Segment of the Eye
1 trial
Frequently asked questions
How many pipeline programs does ANI PHARMACEUTICALS have?
6 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs